PT  - JOURNAL ARTICLE
AU  - Maria Roldan
AU  - Tomas Ysehak Abay
AU  - Christopher Uff
AU  - Panayiotis A. Kyriacou
TI  - A pilot clinical study to estimate intracranial pressure utilising cerebral photoplethysmograms in traumatic brain injury patients
AID  - 10.1101/2023.05.23.23290325
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.05.23.23290325
4099  - http://medrxiv.org/content/early/2023/05/24/2023.05.23.23290325.short
4100  - http://medrxiv.org/content/early/2023/05/24/2023.05.23.23290325.full
AB  - Objective In this research a non-invasive ICP optical sensor has been developed and evaluated in a clinical pilot study. The technology is based on infrared light interrogating brain tissue, including photodetectors used to detect the backscattered light, which is modulated by vascular pulsations in the brain vascular tissue. The hypothesis underpinning this research is based on the expected changes in the extramural arterial pressure affecting the morphology of the recorded optical signals (photoplethysmograms (PPGs)), therefore analysis of the acquired signals using a bespoke algorithm could enable the calculation of the intracranial pressure non-invasively (nICP).Methods This pilot study is the first evaluation of the nICP probe in patients in whom the gold standard comparator of invasive ICP was available. nICP monitoring was performed for up to 48 hours in each of the 40 patients undergoing invasive ICP monitoring as part of their prescribed medical treatment. The quality of the recorded PPG signals was analysed, and time-based features were extracted off-line. Data from all ICP levels were randomly allocated into two groups to train (80%) and test (20%) a machine learning algorithm. A Bland Altman analysis and ROC curve were calculated to evaluate the accuracy of the estimated nICP value compared to the gold standard of synchronously acquired invasive ICP data.Results The successful acquisition of cerebral PPG signals from TBI patients for the subsequent extraction of morphological features allowed the generation of a bagging tree model to estimate ICP non-invasively. The non-invasive estimation of ICP was achieved with 95% limits of agreement of 3.8 mmHg and a negligible bias. Furthermore, the model achieved a good correlation coefficient of 82.54% compared to standard clinical invasive ICP monitoring. Finally, the ROC curve analysis showed good diagnostic capability with a sensitivity of 80% and specificity of 89%.Conclusion Clinical evaluation of this novel optical nICP sensor demonstrated for the first time that it could estimate ICP non-invasively to an acceptable and clinically useful accuracy and paves the way for further technology optimisation and larger clinical studies.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT05632302Funding StatementThe project is funded by the National Institute for Health Research (NIHR) [Invention for Innovation (i4i) Product Development (Grant Reference Number II-LA-0216-20005)]. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The East of England - Cambridge Central Research Ethics Committee approved the protocol on 14/02/19 (REC reference 18/EE/0276, IRAS ID 219476).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors